Skip to main content

Table 5 Medication pathway of antidepressants for the MDNS group in each regimen

From: Real-world evidence from a retrospective study on suicide during depression: clinical characteristics, treatment patterns and disease burden

Switch

Top5

1st regimen

 

Medication

n(%)

 

0 time

n = 2510

1

SSRI + AP

781 (31.12)

 

2

SSRI

516 (20.56)

 

3

SNRI + AP

219 (8.73)

 

4

SNRI

158 (6.29)

2nd regimen

 

5

AP

129 (5.14)

Medication

n(%)

 

1 time

(n = 762)

1

SSRI

141 (18.50)

SSRI + AP

98 (69.50)

 
   

SSRI + NaSSA

17 (12.06)

 
   

SSRI + others

8 (5.67)

 

2

SSRI + AP

119 (15.62)

SSRI

36 (30.25)

 
   

SSRI + AP + MS

29 24.37)

 
   

AP

17 (14.29)

 

3

AP

92 (12.07)

SSRI + AP

69 (75.00)

 
   

AP + MS

15 (16.30)

 
   

SNRI + AP

4 (4.35)

 

4

SNRI

50 (6.56)

SNRI + AP

33 (66.00)

 
   

NaSSA + SNRI

4 (8.00)

 

5

SNRI + AP

41 (5.38)

SNRI

13 (31.71)

 
   

SNRI + AP + MS

9 (21.95)

3rd regimen

   

NaSSA + SNRI + AP

7 (17.07)

Medication

n(%)

2 times

(n = 335)

1

SSRI + AP

65 (19.40)

SSRI + SNRI + AP

21 (32.31)

SNRI + AP

20 (95.24)

   

SSRI + AP + MS

17 (26.15)

AP + MS

11 (64.71)

   

SSRI + SSRI + AP

8 (12.31)

SSRI + AP

7 (87.50)

2

SSRI

56 (16.72)

SSRI + SNRI

14 (25.00)

SNRI

12 (85.71)

   

SSRI + AP

13 (23.21)

SSRI + AP + MS

4 (30.77)

     

SSRI/AP

4 (30.77)

3

SNRI + AP

25 (7.46)

SSRI + SNRI + AP

7 (28.00)

SSRI + AP

7 (100.00)

   

SNRI + AP + MS

5 (20.00)

AP + MS

2 (40.00)

   

NaSSA + SNRI + AP

4 (16.00)

SNRI + AP

3 (75.00)

4

SSRI + NaSSA

24 (7.16)

SSRI + NaSSA + AP

9 (37.50)

SSRI + AP

8 (88.89)

   

SSRI + SSRI + NaSSA

5 (20.83)

SSRI + NaSSA

4 (80.00)

   

SSRI + NaSSA + SNRI

5 (20.83)

NaSSA + SNRI

4 (80.00)

5

AP

20 (5.97)

SSRI + AP

13 (65.00)

SSRI + AP + MS

4 (30.77)

     

SSRI

3 (23.08)

  1. Abbreviations: AD, antidepressants; AP, antipsychotics;MS, mood stabilizers; SSRI, Selective Serotonin Reuptake Inhibitors; SNRI, Serotonin-Norepinephrine Reuptake Inhibitor; NDRI, Norepinephrine Dopamine Reuptake Inhibitor. NaSSA, Noradrenergic and Specific Serotonergic Antidepressant